Ampio Pharmaceuticals, Inc.(NYSE Amex Equities : AMPE)
AMPE PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
Health Technology » Pharmaceuticals Other
|VRX||Valeant Pharmaceuticals International, Inc.||0.00%||29.07||14.1%||$171.05m|
|JAZZ||Jazz Pharmaceuticals Plc||0.00%||179.17||2.2%||$142.15m|
|HZNP||Horizon Therapeutics Plc||0.00%||92.14||5.5%||$124.53m|
|BHC||Bausch Health Cos., Inc.||0.00%||29.07||0.0%||$91.68m|
|SAVA||Cassava Sciences, Inc.||0.00%||40.92||0.0%||$55.78m|
|UTHR||United Therapeutics Corp.||0.00%||197.87||14.0%||$55.65m|
|PRGO||Perrigo Co. Plc||-0.09%||45.82||6.9%||$49.71m|
|SAGE||SAGE Therapeutics, Inc.||0.00%||70.86||7.6%||$33.60m|
|PCRX||Pacira Biosciences, Inc.||0.00%||62.21||9.9%||$30.64m|
|AXSM||Axsome Therapeutics, Inc.||0.00%||58.42||1.9%||$26.79m|
|RVMD||Revolution Medicines, Inc.||0.00%||31.99||0.0%||$23.38m|
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO.